Patents by Inventor Sophie Vaulont

Sophie Vaulont has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of hepcidin as a regulator of iron homeostasis
    Patent number: 10004784
    Abstract: The invention concerns the use of hepcidin for the diagnosis and therapy of disorders of iron homeostasis. Hepcidin can be used in the treatment of disorders resulting from iron overload while inhibitors of hepcidin can be used in the treatment of anaemia.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: June 26, 2018
    Assignee: Institut National de la Sante et de la Recherche Medicale
    Inventors: Gael Nicolas, Sophie Vaulont, Axel Kahn
  • USE OF HEPCIDIN AS A REGULATOR OF IRON HOMEOSTASIS
    Publication number: 20170340710
    Abstract: The invention concerns the use of hepcidin for the diagnosis and therapy of disorders of iron homeostasis. Hepcidin can be used in the treatment of disorders resulting from iron overload while inhibitors of hepcidin can be used in the treatment of anaemia.
    Type: Application
    Filed: August 9, 2017
    Publication date: November 30, 2017
    Inventors: Gael Nicolas, Sophie Vaulont, Axel Kahn
  • Use of hepcidin as a regulator of iron homeostasis
    Patent number: 9782453
    Abstract: The invention concerns the use of hepcidin for the diagnosis and therapy of disorders of iron homeostasis. Hepcidin can be used in the treatment of disorders resulting from iron overload, while inhibitors of hepcidin can he used in the treatment of anaemia.
    Type: Grant
    Filed: June 23, 2015
    Date of Patent: October 10, 2017
    Assignee: Institut National de la Sante et de la Recherche Medicale
    Inventors: Gael Nicolas, Sophie Vaulont, Axel Kahn
  • USE OF HEPCIDIN AS A REGULATOR OF IRON HOMEOSTASIS
    Publication number: 20160166649
    Abstract: The invention concerns the use of hepcidin for the diagnosis and therapy of disorders of iron homeostasis. Hepcidin can be used in the treatment of disorders resulting from iron overload, while inhibitors of hepcidin can he used in the treatment of anaemia.
    Type: Application
    Filed: June 23, 2015
    Publication date: June 16, 2016
    Inventors: Gael Nicolas, Sophie Vaulont, Axel Kahn
  • Hepcidin inhibitors for regulating iron homeostasis
    Patent number: 9234903
    Abstract: The invention concerns the use of hepcidin for the diagnosis and therapy of disorders of iron homeostasis. Hepcidin can be used in the treatment of disorders resulting from iron overload while inhibitors of hepcidin can be used in the treatment of anemia.
    Type: Grant
    Filed: November 21, 2006
    Date of Patent: January 12, 2016
    Assignee: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
    Inventors: Gaël Nicolas, Sophie Vaulont, Axel Kahn
  • Antibodies specific for human hepcidin
    Patent number: 8487081
    Abstract: The present invention relates to antigen-binding proteins having specificity for hepcidin, and their use for treating and diagnosing diseases associated with hepcidin.
    Type: Grant
    Filed: October 2, 2008
    Date of Patent: July 16, 2013
    Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale), Centre National de la Recherche Scientifique-CNRS
    Inventors: Sophie Vaulont, Hugues Gascan, Josy Froger
  • ANTIBODIES SPECIFIC FOR HUMAN HEPCIDIN
    Publication number: 20100285027
    Abstract: The present invention relates to antigen-binding proteins having specificity for hepcidin, and their use for treating and diagnosing diseases associated with hepcidin.
    Type: Application
    Filed: October 2, 2008
    Publication date: November 11, 2010
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Sophie Vaulont, Hugues Gascan, Josy Froger
  • Use of hepcidin as a regulator of iron homeostasis
    Publication number: 20070124825
    Abstract: The invention concerns the use of hepcidin for the diagnosis and therapy of disorders of iron homeostasis. Hepcidin can be used in the treatment of disorders resulting from iron overload while inhibitors of hepcidin can be used in the treatment of anaemia.
    Type: Application
    Filed: November 21, 2006
    Publication date: May 31, 2007
    Inventors: Gael Nicolas, Sophie Vaulont, Axel Kahn
  • Use of hepcidin as a regulator of iron homeostasis
    Patent number: 7169758
    Abstract: The invention concerns the use of hepcidin for the diagnosis and therapy of disorders of iron homeostasis. Hepcidin can be used in the treatment of disorders resulting from iron overload, while inhibitors of hepcidin can he used in the treatment of anaemia.
    Type: Grant
    Filed: May 24, 2002
    Date of Patent: January 30, 2007
    Assignee: Institut National de la Sante et de la Recherche Medicale (Inserm)
    Inventors: Gaël Nicolas, Sophie Vaulont, Axel Kahn
  • Use of hepcidin as a regulator of iron homeostasis
    Publication number: 20050037971
    Abstract: The invention concerns the use of hepeidin for the diagnosis and therapy of disorders of iron homeostasis. Hepeidin can be used in the treatment of disorders resulting from iron overload, while inhibitors of hepeidin can he used in the treatment of anaemia.
    Type: Application
    Filed: May 24, 2002
    Publication date: February 17, 2005
    Inventors: Gael Nicolas, Sophie Vaulont, Axel Kahn